Chemical degradation and determination of pheomelanin and eumelanin markers

By Kazumasa Wakamatsu
View Published Protocol

Output Details

Description
This is protocol involving chemical oxidation and reduction methods followed by high performance liquid chromatography (HPLC) detection of markers for pheomelanin and eumelanin.
Identifier (DOI)
10.17504/protocols.io.36wgqjz43vk5/v1
Team
Team Chen
Program
Collaborative Research Network
Theme
Neuro-Immune Interactions

Meet the Authors

  • User avatar fallback logo

    Kazumasa Wakamatsu

Related Research

DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease

Neuromelanin in the substantia nigra may be a key factor contributing to dopaminergic neuron vulnerability in Parkinson’s disease. Here, the authors investigated the relative composition and specific roles of pheomelanin and eumelanin in PD.

View Article

Dynamic basal ganglia output signals license and suppress forelimb movements

Basal ganglia is fundamental to motor control and dysfunction is linked to motor deficits. Our results demonstrate the existence and function of highly specific and temporally precise movement representations in basal ganglia output circuitry.

View Article

Mouse Stereotaxic Surgery-Arber Lab

This protocol describes the steps for performing stereotaxic surgery in mice. It is applicable to intracranial injections (e.g. virus, drug) and placement of implants (e.g. optical fibers, electrode arrays) into targeted regions of mouse brains.

View Protocol
View More Outputs